HuagongsheHuagongshe Chemistry Print Report · For research reference only
Dapagliflozin → HCID 131728579, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Dapagliflozin | HCID 9887712 | — |
| Reactant | HCID 56841155 | HCID 56841155 | — |
| Product | HCID 131728579 | HCID 131728579 | — |
Reaction Steps
Tablets containing the SGLT2 inhibitor dapagliflozin or dapagliflozin propylene glycol hydrate were prepared in strengths of 2.5 mg (Example 7), 10 mg (Example 8) and 50 mg (Example 9) as described below.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08716251B2 |
| Source dataset | uspto-grants-2014_05 |
| ORD ID | ord-3298eb4ef70944ef979486109caef090 |
| Source note | uspto-grants-2014_05 |